Abstract CT098: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced IDH-mutant cholangiocarcinoma and other solid tumors (original) (raw)

Abstract CT098: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced IDH-mutant cholangiocarcinoma and other solid tumors

Cancer Research, 2023

Kamnesh Pradhan

Kamnesh Pradhan hasn't uploaded this paper.

Let Kamnesh know you want this paper to be uploaded.

Ask for this paper to be uploaded.